The call for action comes because the government developed the use of Truvada as PrEP but Gilead Sciences is making all the money from it.
The Pennsylvania lawmaker said the LGBTQ community must not allow shame to sully the HIV preventative.
The U.S. government, which developed and patented the use of Truvada for PrEP, got nothing.
He had been on an on-demand PrEP strategy for over five years, but was later diagnosed in December.
Use of the drug jumped six-fold from 2012 to 2017, but officials still want more people on PrEP.
Mutual of Omaha will no longer deny policies to people using the preventative HIV drug.
